本刊讯近日,北京世纪坛医院整形美容外科与中心实验室合作开展科研临床工作,将富含血小板纤维蛋白新技术应用于慢性难愈性创面的临床治疗。治疗包含糖尿病足、结核性伤口、血管性疾病导致的慢性创面等患者,均取得了满意的治疗效果。不仅缩短了患者的病程,减少了患者来院就医的次数, Recently, Beijing Shijitan Hospital Plastic Surgery Department and the Central Laboratory to carry out scientific research clinical work, the platelet fibrin technology rich in clinical application of chronic refractory wounds. Treatment includes diabetic foot, tuberculous wounds, vascular diseases caused by chronic wounds and other patients, have achieved satisfactory therapeutic effect. Not only shorten the patient’s course, reducing the number of patients to hospital for medical treatment,